Frequently Asked Questions

Corporate information

At year-end 2022, Bavarian Nordic had 975 full-time employees.

Bavarian Nordic has subsidiaries in USA, Germany and Switzerland. See more under Locations.

Bavarian Nordic has four commercial products:

  • Rabipur/RabAvert - rabies vaccine
  • Encepur - tick-borne encephalitis vaccine
  • JYNNEOS/IMVANEX/IMVAMUNE - smallpox/monkeypox vaccine
  • MVABEA - Ebola vaccine (licensed to Janssen)


Bavarian Nordic shares are traded on Nasdaq Copenhagen under the ticker symbol BAVA.

An ADR program has been established allowing U.S. investors to trade the stock locally on the OTC market under the ticker symbol BVNRY.

Bavarian Nordic has approximately 120,000 registered shareholders (March 2023).

Bavarian Nordic has 77,873,061 outstanding shares.

No, but Bavarian Nordic stock can be purchased through just about any brokerage firm, including online brokerage services.

Bavarian Nordic has never declared dividends. We intend on retaining all future earnings to finance future growth and therefore, do not anticipate paying any cash dividends in the foreseeable future.

The Company’s register of shareholders is kept by Computershare A/S, who also maintains our shareholder portal.  If you are a registered shareholder, you can access the shareholder portal and view your holding of shares and register your e-mail address to receive certain electronic investor information. You can also request admission card and/or vote for the annual general meeting.

Computershare A/S
Lottenborgvej 26 D, 1.
DK-2800 Kgs. Lyngby

Phone: +45 4546 0999

If you own shares through a bank or brokerage firm, you need to contact the bank or brokerage firm directly to change your account address.

The 2023 annual general meeting was held on March 30, 2023. See Events & Presentations for more details.


Bavarian Nordic's fiscal year runs from January 1 to December 31.

Our annual report is published electronically as a PDF file only.


At Bavarian Nordic we are committed to being socially and environmentally responsible and to comply with all relevant laws, standards and guidelines. We maintain a strong corporate governance structure and communicate openly and transparently about our efforts.

More information can be found on the Corporate Governance and Sustainability sections of this website.